trial · primary record
HMPL-306 tablet
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 210 |
| Primary completion | 2032-09 |
| Primary endpoint | PFS assessed by BIRC (according to Response Assessment in Neuro-Oncology [RANO] 2.0 criteria) |
| Registry ID | NCT07912398 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:37.114Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07912398
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.